Maltogenic alpha-amylase variants
View Patent ↗The inventors have modified the amino acid sequence of a maltogenic alpha-amylase to obtain variants with improved properties, based on the three-dimensional structure of the maltogenic alpha-amylase Novamyl. The variants have altered physicochemical properties., e.g. an altered pH optimum, improved thermostability, increased specific activity, an altered cleavage pattern or an increased ability to reduce retrogradation of starch or staling of bread.
1. A method of constructing a variant of a parent maltogenic alpha-amylase, wherein said parent maltogenic alpha-amylase has an amino acid sequence which is at least 70% identical to amino acid residues 1-686 of SEQ ID NO:2, and wherein said parent maltogenic alpha-amylase has an active site which comprises a cluster of three amino acid residues corresponding to positions D329, D228 and E256 in SEQ ID NO:2, which method comprises:
a) modeling the parent alpha-amylase on the three-dimensional structure of amino acid residues 1-686 of SEQ ID NO:2 depicted in the Appendix to produce a three-dimensional structure of the parent alpha-amylase;
b) identifying in said three-dimensional structure of the parent alpha-amylase an amino acid residue which (i) is within 15 Å of one of said three amino acid residues and (ii) is involved in electrostatic or hydrophobic interactions with an active site residue: and
c) constructing the variant by substituting the amino acid residue identified in said b) with another amino add residue which changes the electrostatic and/or hydrophobic surroundings of said active site residue wherein the variant has maltogenic alpha-amylase activity.
2. The method of claim 1 , wherein said b) comprises identifying in said three dimensional structure of the parent alpha-amylase an amino acid residue which (i) is within 10 Å of one of said three amino acid residues and (ii) is involved in electrostatic or hydrophobic interactions with an active site residue.
3. The method of claim 1 , wherein the method further comprises
d) testing the pH dependent activity of said variant constructed in said c); and
e) selecting a variant having an altered pH dependent activity as compared to the parent amylase.
4. The method of claim 1 , wherein said parent maltogenic alpha-amylase is at least 80% identical to amino acid residues 1-886 of SEQ ID NO:2.
5. The method of claim 1 , wherein said parent maltogenic alpha amylase is at least 90% identical to amino acid residues 1-686 of SEQ ID NO:2.
6. The method of claim 1 , wherein said parent maltogenic alpha-amylase is at least 95% identical to amino acid residues 1-686 of SEQ ID NO:2.
7. The method of claim 1 , wherein said parent maltogenic alpha-amylase is at least 98% identical to amino add residues 1-686 of SEQ ID NO:2.
8. The method of claim 1 , wherein said parent maltogenic alpha-amylase has the amino acid sequence of amino acid residues 1686 of SEQ ID NO:2.
9. The method of claim 1 , wherein the method comprises repeating steps b) and c) at least once.
10. The method of claim 1 , herein the method further comprises d) repeating steps b) and c);
e) after the completion of step d, preparing the variant resulting from steps a)-d);
f) testing the pH dependent activity of said variant; and
g) selecting a variant having maltogenic alpha-amylase activity and having an altered pH dependent activity as compared to the parent amylase.
11. The method of claim 1 , wherein the method further comprises
d) repeating steps b) and c);
e) making alterations each of which is an insertion, a deletion or a substitution of an amino acid residue at one or more positions other than c);
f) after the completion of step e, preparing the variant resulting from steps a)-e);
g) testing the pH dependent activity of said variant; and
h) selecting a variant having maltogenic alpha-amylase activity and an altered pH dependent activity as compared to the parent amylase.
12. The method of claim 1 , wherein the method further comprises:
d) repeating steps b) and c);
e) making alterations each of which is an insertion, a deletion or a substitution of an amino acid residue at one or more positions other than c);
f) after the completion of step e, preparing the variant resulting from steps a)-e);
g) testing the pH dependent activity of said variant;
h) repeating steps a)-g); and
i) selecting a variant having maltogenic alpha-amylase activity and an altered pH dependent activity as compared to the parent amylase.
13. The method of claim 2 , wherein said parent maltogenic alpha-amylase is at least 80% identical to amino acid residues 1886 of SEQ ID NO:2.
14. The method of claim 2 , wherein said parent maltogenic alpha amylase is at least 90% identical to amino acid residues 1486 of SEQ ID NO:2.
15. The method of claim 2 , wherein said parent maltogenic alpha-amylase is at least 95% identical to amino acid residues 1-686 of SEQ ID NO:2.
16. The method of claim 2 , wherein said parent maltogenic alpha-amylase is at least 98% identical to amino acid residues 1-686 of SEQ ID NO:2.
17. The method of claim 2 , wherein said parent maltogenic alpha-amylase has the amino acid sequence of amino acid residues 1686 of SEQ ID NO:2.